Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.00645
+0.00015 (2.38%)
At close: Nov 9, 2026
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $854.82 thousand as of November 10, 2026. It is the 49,678th most valuable company in the world and the 6,739th biggest in the United States. Its market cap has decreased by 25.03% in one year.
Market Cap
854.82K
Enterprise Value
60.06M
Revenue
18.05M
Global Rank
Country Rank
#6,739 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 854.82K, a decrease of -99.60%. That is a compound annual growth rate of -46.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 854.82K | -28.97% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.35M |
| inTerra Resources | 1.30M |
| Halberd | 1.27M |
| AXIM Biotechnologies | 1.17M |
| International Stem Cell | 1.16M |
| Protagenic Therapeutics | 977.51K |
| Helix BioMedix | 739.29K |
| SQZ Biotechnologies Company | 707.79K |